Pharmacologic control of thromboembolic complications of cardiac-valve replacement

The New England Journal of Medicine
J M SullivanR Gorlin

Abstract

No abstract listed.

References

Sep 25, 1965·Lancet·P R EmmonsJ R Mitchell
Nov 9, 1968·British Medical Journal·A E GentT N Miller
Mar 8, 1969·British Medical Journal·J AchesonE C Hutchinson
Jul 1, 1970·Circulation·J F Mustard, M A Packham
Sep 1, 1969·Scandinavian Journal of Clinical and Laboratory Investigation·R Eliasson, S Bygdeman
Dec 10, 1970·The New England Journal of Medicine·L A Harker, S J Slichter
May 1, 1968·The American Journal of the Medical Sciences·J M SullivanR Gorlin
Sep 12, 1968·The New England Journal of Medicine·J M SullivanR Gorlin
Dec 1, 1968·Scottish Medical Journal·G R GrayA S Douglas
Aug 1, 1963·The Journal of Physiology·G V BORN, M J CROSS
Mar 13, 1965·British Medical Journal·H LANDERH N ROBSON

❮ Previous
Next ❯

Citations

Jan 1, 1982·European Journal of Clinical Pharmacology·J O MinersD J Birkett
Dec 1, 1989·Cardiovascular Drugs and Therapy·B Stein, V Fuster
May 15, 1976·Experientia·J Aznar, J Valles
Jan 1, 1982·Annals of Biomedical Engineering·F J SchoenG M Lawrie
Jan 28, 1974·Albrecht Von Graefes Archiv Für Klinische Und Experimentelle Ophthalmologie. Albrecht Von Graefe's Archive for Clinical and Experimental Ophthalmology·I M WilliamsJ Dixon
Mar 1, 1973·Canadian Anaesthetists' Society Journal·J G MailléM Boulanger
Jun 1, 1979·The American Journal of Cardiology·J I Haft
Aug 1, 1986·The Journal of Surgical Research·R W BiancoJ E Foker
Jul 1, 1979·Progress in Cardiovascular Diseases·A I Schafer, R I Handin
Dec 1, 1989·Controlled Clinical Trials·J P Boissel
Oct 1, 1989·Journal of the American College of Cardiology·B SteinJ H Chesebro
Mar 1, 1994·Journal of the American College of Cardiology·J HayashiS Eguchi
Aug 1, 1976·American Heart Journal·G E Burch, T D Giles
Jan 1, 1975·The Annals of Thoracic Surgery·N W SalomonB C Paton
Dec 1, 1986·Journal of the American College of Cardiology·L A Harker, V Fuster
Dec 1, 1986·Journal of the American College of Cardiology·J H ChesebroV Fuster
Feb 1, 1986·Journal of the American College of Cardiology·C R KlimtP Meier
Jun 3, 2000·Gastroenterology Clinics of North America·H HussainM S Cappell
Aug 1, 1997·Cardiovascular Surgery : Official Journal of the International Society for Cardiovascular Surgery·G S Hillis, K P Jennings
Aug 12, 2000·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·C F Schanbacher, R G Bennett
Mar 30, 2013·Seminars in Thrombosis and Hemostasis·Gregory J del Zoppo
Feb 17, 1972·The New England Journal of Medicine·E W Salzman
Nov 16, 1972·The New England Journal of Medicine·L A Harker, S J Slichter
May 31, 1973·The New England Journal of Medicine·P P SteeleE Genton
Dec 4, 1975·The New England Journal of Medicine·E GentonL A Harker
Jun 22, 1978·The New England Journal of Medicine·H J Weiss
Sep 6, 1984·The New England Journal of Medicine·S Wessler, S N Gitel
Aug 19, 1993·The New England Journal of Medicine·A G TurpieJ Hirsh
Sep 2, 1993·The New England Journal of Medicine·M H EckmanS G Pauker
Aug 8, 1996·The New England Journal of Medicine·W VongpatanasinR A Lange
Jan 12, 2010·Cardiovascular Research·Prasanna K VenkateshChristopher G Kevil
Jun 19, 2004·International Anesthesiology Clinics·Carlos A Puyo
Apr 24, 1976·British Medical Journal·J T RenneyP F Burke
Jun 10, 1978·British Medical Journal
Jul 28, 1979·British Medical Journal·D Pitcher, P Curry
Jul 8, 1972·British Medical Journal
May 1, 1978·British Heart Journal·M G SuttonM Paneth
Sep 1, 1979·British Heart Journal·S M RajahD A Watson
Jun 1, 1985·Journal of Neurology, Neurosurgery, and Psychiatry·K Sotaniemi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.